Hematoma
epidural, 121–123, 143–144
subdural
description of, 123–126, 124t
posterior fossa, 144
Hemiparesis, 101, 106
Hemodialysis, for uremia, 229
Hemorrhage
brainstem, 166–168
cerebellar. See Cerebellar hemorrhage
intraventricular, 137
lobar, 136, 136f
midbrain, 166t, 167
perimesencephalic, 145
pontine
clinical findings of, 167t
coma caused by, 167
description of, 138b, 150–151
origin of, 167
pupillary findings, 167
subarachnoid
description of, 129–131, 139b
grading system for, 356t
outcomes after, 355–356
posterior fossa, 145
thalamic, 137, 138b, 139
into tumors, 140
Hepatic coma
description of, 190, 225
prognosis for, 356–357
Hepatic encephalopathy
diagnosis of, 225
hyperventilation associated with, 224
mild, 227
onset of, 224
pathology of, 224
pupillary findings in, 225
Herniation syndromes
central transtentorial herniation, 101–102, 107–110
corticosteroids for, 322
falcine herniation, 100
historical view of, 97b
intracranial compartments, 95–100
lateral displacement of the diencephalon, 97b, 100
Monroe-Kellie doctrine, 95
rostrocaudal brainstem deterioration, 102
tonsillar, 102, 103f–104f
uncal. See Uncal herniation
upward brainstem herniation, 102–103
Heroin, 243
Herpes simplex encephalitis, 157, 157t, 267–269, 315
Herpes zoster, 275–276
Herring-Breuer reflex, 49
Hiccupping, 53
Hippocampus
bilateral, 31–32
CA1 region of, 30
Histamine, 209–210
Histidine decarboxylase, 18, 209
History-taking, 39–40, 317–318
Histotoxic hypoxia, 211
Horner’s syndrome
central, 57–58
clinical features of, 55
peripheral, 58
Hyperarousal, 183–184
Hyperbaric oxygenation, 325
Hypercalcemia, 256–257
Hypercarbia, 230
Hyperglycemia, 203, 222–223, 234, 313
Hyperglycemic hyperosmolar coma, 256
Hyperkinetic movement disorders, 28
Hypermagnesemia, 258
Hypernatremia, 255–256
Hypernatremic encephalopathy, 256
Hyperosmolality, 232
Hyperosmolar agents, 321–322
Hyperosmolar states, 255–256
Hyperphosphatemia, 258
Hypersomnia, 8
Hyperthermia, 260–262, 315
Hyperthyroidism, 237
Hyperventilation
acid-base imbalances with
metabolic acidosis, 188–189
respiratory alkalosis, 189–191, 190t
in comatose patients, 51
in hepatic encephalopathy, 224
intracranial pressure reduced with, 321
sepsis and, 190
Hypocalcemia, 257–258
Hypocretin, 21b, 115. See also Orexin
Hypoglycemia, 203–205, 234, 313
Hypomagnesemia, 258
Hyponatremia, 228–229, 237, 252f, 253–255
Hyponatremic encephalopathy, 254t
Hypo-osmolar states, 253–255
Hypophosphatemia, 258
Hypothalamic ischemic lesions, 33
Hypothermia, 259–260, 315, 335
Hypothyroidism, 236–237
Hypoventilation, 191–192, 230
Hypoxia
acute, 211–214
airway obstruction and, 211
anemic, 211
anoxic-ischemic brain damage caused by, 208
carbon dioxide narcosis and, 231
causes of, 210–211
cerebral malaria and, 217
cerebral venous, 211
delayed postanoxic encephalopathy
after, 219
disseminated intravascular coagulation
and, 217
fat embolism and, 217
histotoxic, 211
hypoxic, 211
intermittent, 215–219
ischemic, 211
multifocal cerebral ischemia and, 215–216
pupillary responses in, 59
sequelae of, 219–220
sustained, 215–219
traumatic brain injury and, 346
Hypoxic inducible factor, 212
Hypoxic-ischemic attacks, 212
Hypoxic-ischemic encephalopathy,
352–354
Hysteresis, 50–51
Index
393
Immunosuppression, 229–230
Infarction
brainstem, 165t
cerebellar, 139b, 148–149, 324
cerebral artery, 153f
thalamic, 154
Wallenberg’s lateral medullary, 59
Infection
central nervous system. See Central nervous
system infections
opportunistic, 230
prion, 266, 277–278
subarachnoid, 131–135
treatment of, 315
Infratentorial inflammatory disorders, 169–170
Infratentorial lesions
compressive, 142–143
destructive, 162–163
mass, 323–324
Infratentorial tumors, 170
Insulin, 202
Intensive care unit delirium, 283–284
Intention myoclonus, 220
Intermittent hypoxia, 215–219
Internuclear ophthalmoplegia, 63, 76
Interstitial nucleus of Cajal, 62
Intoxication. See also Drug intoxications
drugs of abuse, 248
ethanol, 246, 248
methanol, 249
paraldehyde, 249–250
Intracerebral hemorrhage
computed tomography of, 136f
lobar hemorrhage, 136, 136f
pathophysiology of, 135–136, 139–140
treatment of, 137
Intracerebral tumors, 140–141
Intracranial compartments, 95–100
Intracranial hypertension, 321, 323
Intracranial pressure, increased
abducens palsy caused by, 113
cerebral arterial supply impairment
secondary to, 92
compensatory mechanisms of brain to, 92–93
headaches caused by, 92
hyperventilation for, 321
papilledema caused by, 91–92
paroxysmal symptoms caused by, 93t
patient positioning, 312
reduction of, 321
Intraventricular hemorrhage, 137
Intubation, 311–312
Ischemia
focal, 207–208
global, 206–207
vertebrobasilar, 213
Ischemic anoxia, 212
Ischemic hypoxia, 211
Ischemic lesions, carotid, 152
Kernig sign, 133, 263
Kernohan’s notch, 101
Ketamine, 248
Ketone bodies, 202
Kussmaul breathing, 75–76
Laboratory tests
blood tests, 77
computed tomography. See Computed tomography
computed tomography angiography, 78
electroencephalography, 82–83
evoked potentials, 82–83
lumbar puncture. See Lumbar puncture
magnetic resonance angiography, 79, 336
magnetic resonance imaging. See Magnetic
resonance imaging
magnetic resonance spectroscopy, 79–80
neurosonography, 80
urine tests, 77
Lactate, 80, 203
Lactic acidosis, 233, 250
Lateral displacement of the diencephalon, 97b, 100
Lateral rectus muscle, 60–61
Lateral sinus thrombosis, 92, 154
Lazarus sign, 334
Leptomeningeal tumors, 131
Leptomeningitis, 262–265
Level of consciousness
determination of, 5, 9
evaluation of, 40, 42
reduced, 5
Libman-Sachs endocarditis, 274
Lipid peak, 80
Listeria meningitis, 132
Listeria monocytogenes, 116, 170, 263, 315
Lithium, 242t, 245–246
Liver failure
acute, 224
chronic, 224
Lobar hemorrhage, 136, 136f
Locked-in syndrome/state, 7, 363–364, 380
Locus coeruleus, 15
Loss of consciousness
from cerebral blood flow reductions, 201
in concussion, 161
fractional, 5, 27
Lower motor neuron palsy, 113
Lumbar puncture
description of, 80–82
safety of, 112–113
in subdural hematoma patient, 126
Magnetic resonance angiography, 79, 336
Magnetic resonance imaging
description of, 78–79
fat embolism evaluations, 217–218
hepatic encephalopathy evaluations, 225, 226f
herpes simplex encephalitis findings, 158f
Marchiafava-Bignami disease evaluations, 278
meningeal tumors, 132f
meningioma evaluation, 127
meningitis evaluation, 135t, 264f
minimally conscious state findings, 370f
progressive multifocal leukoencephalopathy
evaluations, 280f
subarachnoid hemorrhage findings, 130
subdural hematoma evaluations, 125
Magnetic resonance spectroscopy, 79–80
Malaria, cerebral, 217
Malignant hyperthermia, 262
Malingering, 299–300
394
Index
Dostları ilə paylaş: |